$900 million sale of pharmaceuticals division

At last the day has finally come!

The announcement should be out today concerning the ACCC's decision about the $900 Million Sale of Pharmaceuticals Division to Aspen Pharmacare. Good luck to all the holders and hopefully the sp absolutely flies. All investors are confident concerning ACCC approval therefore if the sale goes through with our current market capital of around $550 million, the extra $900 million means that this company is way undervalued. Even if the sale does not go through, the Pharmaceuticals division is one of our greatest revenue earners therefore the company is still greatly undervalued. I wish you all the best of luck!

Regards,

GC